Evonik Evonik

X

Find Seladelpar manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

0

US DMFs Filed

US DMFs Filed

0

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

0

API REF. PRICE (USD / KG)

0

INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

0

Annual Reports

0

EXCIPIENTS

0

PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Seladelpar
Also known as: 851528-79-5, Mbx-8025, Seladelpar [inn], Seladelpar [usan], Rwj-800025, Chembl230158
Molecular Formula
C21H23F3O5S
Molecular Weight
444.5  g/mol
InChI Key
JWHYSEDOYMYMNM-QGZVFWFLSA-N
FDA UNII
7C00L34NB9

Seladelpar (MBX-8025) has been used in trials studying the treatment of Hyperlipidemia.
1 2D Structure

Seladelpar

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
2-[4-[(2R)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic acid
2.1.2 InChI
InChI=1S/C21H23F3O5S/c1-3-27-17(11-28-16-6-4-15(5-7-16)21(22,23)24)13-30-18-8-9-19(14(2)10-18)29-12-20(25)26/h4-10,17H,3,11-13H2,1-2H3,(H,25,26)/t17-/m1/s1
2.1.3 InChI Key
JWHYSEDOYMYMNM-QGZVFWFLSA-N
2.1.4 Canonical SMILES
CCOC(COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C
2.1.5 Isomeric SMILES
CCO[C@H](COC1=CC=C(C=C1)C(F)(F)F)CSC2=CC(=C(C=C2)OCC(=O)O)C
2.2 Other Identifiers
2.2.1 UNII
7C00L34NB9
2.3 Synonyms
2.3.1 MeSH Synonyms

1. (4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)sulfanyl)-2-methylphenoxy)acetic Acid

2.3.2 Depositor-Supplied Synonyms

1. 851528-79-5

2. Mbx-8025

3. Seladelpar [inn]

4. Seladelpar [usan]

5. Rwj-800025

6. Chembl230158

7. 7c00l34nb9

8. Mbx 8025

9. 851528-79-5 (free Base)

10. (r)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)acetic Acid

11. (+)-mbx-8025

12. ((4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenyl)oxy)acetic Acid

13. 2-[4-[(2r)-2-ethoxy-3-[4-(trifluoromethyl)phenoxy]propyl]sulfanyl-2-methylphenoxy]acetic Acid

14. Acetic Acid, (4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)-

15. Acetic Acid, 2-(4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)-

16. Seladelpar (usan/inn)

17. Seladelpar [usan:inn]

18. Seladelpar [who-dd]

19. Schembl392331

20. Unii-7c00l34nb9

21. Gtpl11137

22. Mbx8025

23. Dtxsid001045332

24. Bjb52879

25. Ex-a1512

26. Bdbm50213714

27. Akos037649258

28. Db12390

29. Compound 3r [pmid: 17524639]

30. Ac-36246

31. Bs-17646

32. Hy-19522

33. Mbx-8025; Rwj-800025

34. Cs-0015622

35. C76734

36. D11256

37. A914807

38. Q27268037

39. (r)-2-(4-(2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propylthio)-2-methylphenoxy)acetic Acid

40. (4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)sulfanyl)-2-methylphenoxy)acetic Acid Peroxisome Proliferator Activated Receptor (ppar) Agonist,antihyperlipidaemic

41. (r)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)-thio)-2-methylphenoxy)acetic Acid

42. Acetic Acid, (4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)- ((4-(((2r)-2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenyl)oxy)acetic Acid

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 444.5 g/mol
Molecular Formula C21H23F3O5S
XLogP35.2
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count9
Rotatable Bond Count11
Exact Mass444.12182949 g/mol
Monoisotopic Mass444.12182949 g/mol
Topological Polar Surface Area90.3 Ų
Heavy Atom Count30
Formal Charge0
Complexity511
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Treatment of primary biliary cholangitis


5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Hypolipidemic Agents

Substances that lower the levels of certain LIPIDS in the BLOOD. They are used to treat HYPERLIPIDEMIAS. (See all compounds classified as Hypolipidemic Agents.)


Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY